Influenza, Human
Welcome,         Profile    Billing    Logout  
 66 Companies   64 Products   64 Products   38 Mechanisms of Action   0 Trials   1520 News 


«12345678910111213...3031»
  • ||||||||||  paracetamol / Generic mfg., ibuprofen / Generic mfg.
    Trial primary completion date:  The Benefit and Harm of Fever Suppression by Antipyretics in Influenza (clinicaltrials.gov) -  Dec 5, 2015   
    P4,  N=400, Recruiting, 
    Recruiting --> Completed Trial primary completion date: Sep 2015 --> Dec 2017
  • ||||||||||  oseltamivir / Generic mfg.
    Trial completion, Trial primary completion date:  A Study of Intravenous Tamiflu (Oseltamivir) in Children With Influenza (clinicaltrials.gov) -  Nov 11, 2015   
    P1,  N=7, Completed, 
    Trial primary completion date: Sep 2015 --> Feb 2016 Active, not recruiting --> Completed | Trial primary completion date: May 2013 --> Jul 2012
  • ||||||||||  Trial completion:  Protecting Pregnant Women From Infectious Diseases (clinicaltrials.gov) -  Nov 10, 2015   
    P=N/A,  N=330, Completed, 
    Active, not recruiting --> Completed | Trial primary completion date: May 2013 --> Jul 2012 Active, not recruiting --> Completed
  • ||||||||||  Fluzone High-Dose Quadrivalent (influenza vaccine) / Evotec, Sanofi
    Trial primary completion date:  Duration of Immune Response to Influenza Vaccination in Patients With RA (clinicaltrials.gov) -  Nov 6, 2015   
    P4,  N=90, Active, not recruiting, 
    Active, not recruiting --> Completed Trial primary completion date: Sep 2015 --> Dec 2015
  • ||||||||||  Trial primary completion date:  Two-site Intradermal Influenza Vaccination in Elderly (clinicaltrials.gov) -  Oct 23, 2015   
    P=N/A,  N=180, Recruiting, 
    Recruiting --> Active, not recruiting Trial primary completion date: Dec 2012 --> Dec 2016
  • ||||||||||  HibTITER (diphtheria crm197 protein conjugate) / Nuron Biotech, Mitsubishi Tanabe
    Trial completion:  Exploratory Clinical Study of MT-2301 (clinicaltrials.gov) -  Oct 20, 2015   
    P2,  N=157, Completed, 
    Trial primary completion date: Jul 2012 --> Apr 2012 Active, not recruiting --> Completed
  • ||||||||||  Clinical data, Trial completion, Enrollment change, Trial initiation date, Trial primary completion date:  Comparison of Epidemiology and Clinical Outcomes of Influenza A & B Cases in Manitoba, Canada (clinicaltrials.gov) -  Oct 20, 2015   
    P=N/A,  N=1849, Completed, 
    Active, not recruiting --> Completed Not yet recruiting --> Completed | N=1280 --> 1849 | Initiation date: Sep 2012 --> Apr 2012 | Trial primary completion date: Feb 2013 --> Sep 2012
  • ||||||||||  Inactivated Quadrivalent Influenza Vaccine (Split Virion) (influenza vaccine) / Jiangsu Jindike Biotechnology
    Trial completion, Enrollment change:  A Phase I Clinical Trial for Inactivated Quadrivalent Influenza Vaccine (Split Virion) in Healthy Adults in China (clinicaltrials.gov) -  Oct 14, 2015   
    P1,  N=110, Completed, 
    Not yet recruiting --> Completed | N=1280 --> 1849 | Initiation date: Sep 2012 --> Apr 2012 | Trial primary completion date: Feb 2013 --> Sep 2012 Active, not recruiting --> Completed | N=40 --> 110
  • ||||||||||  Trial completion, Enrollment change:  Brief Influenza Vaccine Education to Pregnant Women (clinicaltrials.gov) -  Oct 10, 2015   
    P=N/A,  N=321, Completed, 
    Active, not recruiting --> Completed | N=40 --> 110 Active, not recruiting --> Completed | N=184 --> 321
  • ||||||||||  Enrollment closed, Trial primary completion date:  Text Messaging Reminders for Influenza Vaccine in Primary Care (clinicaltrials.gov) -  Oct 7, 2015   
    P=N/A,  N=60, Active, not recruiting, 
    Recruiting --> Active, not recruiting Not yet recruiting --> Active, not recruiting | Trial primary completion date: May 2014 --> Dec 2015
  • ||||||||||  Enrollment closed, Enrollment change:  Testing the AVI-7100 Flu Drug in Healthy Volunteers (clinicaltrials.gov) -  Oct 1, 2015   
    P1,  N=50, Active, not recruiting, 
    Active, not recruiting --> Completed Recruiting --> Active, not recruiting | N=150 --> 50
  • ||||||||||  Trial completion:  A(H7N9) VLP Antigen Dose-Ranging Study With Matrix-M1 (clinicaltrials.gov) -  Oct 1, 2015   
    P1/2,  N=610, Completed, 
    Recruiting --> Active, not recruiting | N=150 --> 50 Active, not recruiting --> Completed
  • ||||||||||  Trial primary completion date:  SCID Bu/Flu/ATG Study With T Cell Depletion (clinicaltrials.gov) -  Sep 25, 2015   
    P1/2,  N=15, Enrolling by invitation, 
    Active, not recruiting --> Completed Trial primary completion date: Jul 2015 --> Dec 2015
  • ||||||||||  Fluzone (influenza vaccine) / Sanofi
    Enrollment open:  Immune and Hormone Response to Influenza Vaccine (clinicaltrials.gov) -  Sep 18, 2015   
    P4,  N=100, Recruiting, 
    N=51 --> 0 | Terminated --> Withdrawn Active, not recruiting --> Recruiting
  • ||||||||||  Trial completion, Enrollment change:  Arm Pump in Motorcross Training (clinicaltrials.gov) -  Sep 17, 2015   
    P=N/A,  N=11, Completed, 
    Recruiting --> Completed | N=200 --> 74 | Trial primary completion date: Dec 2015 --> Sep 2015 Recruiting --> Completed | N=40 --> 11
  • ||||||||||  Trial primary completion date:  ResPECT: The Respiratory Protection Effectiveness Clinical Trial (clinicaltrials.gov) -  Sep 2, 2015   
    P=N/A,  N=1600, Active, not recruiting, 
    Recruiting --> Completed | N=40 --> 11 Trial primary completion date: Mar 2015 --> May 2017
  • ||||||||||  Trial completion:  Immunogenicity of H5N1 Vaccine Following H5N2 (clinicaltrials.gov) -  Aug 29, 2015   
    P2,  N=43, Completed, 
    Trial primary completion date: Mar 2015 --> May 2017 Active, not recruiting --> Completed
  • ||||||||||  Ampligen (rintatolimod) / AIM ImmunoTech
    Trial primary completion date:  Safety Study of FluMist With and Without Ampligen (clinicaltrials.gov) -  Aug 21, 2015   
    P1/2,  N=72, Recruiting, 
    Trial primary completion date: Apr 2015 --> Apr 2016 Trial primary completion date: Jun 2015 --> Jun 2016
  • ||||||||||  Pentacel (diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus and hemophilus b conjugate) / Sanofi
    Trial completion, Enrollment change:  Database Surveillance Safety Study of PENTACEL® Vaccine (clinicaltrials.gov) -  Aug 20, 2015   
    P=N/A,  N=62538, Completed, 
    Trial primary completion date: Jun 2015 --> Jun 2016 Active, not recruiting --> Completed | N=10000 --> 62538
  • ||||||||||  Vaxigrip (inactivated influenza vaccine (split virion)) / Sanofi
    Phase classification, Enrollment change, Trial primary completion date, Adverse events:  IVVE:Pilot: Influenza Vaccine To Prevent Adverse Vascular Events:Pilot (clinicaltrials.gov) -  Aug 12, 2015   
    P4,  N=3500, Recruiting, 
    Trial primary completion date: Nov 2015 --> Jul 2017 Phase classification: P2 --> P4 | N=600 --> 3500 | Trial primary completion date: Dec 2015 --> Dec 2019
  • ||||||||||  Enrollment closed, Trial primary completion date:  Micronutrient Supplementation and Incidence of Common Cold (clinicaltrials.gov) -  Aug 11, 2015   
    P=N/A,  N=82, Active, not recruiting, 
    Phase classification: P2 --> P4 | N=600 --> 3500 | Trial primary completion date: Dec 2015 --> Dec 2019 Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2015 --> Oct 2015
  • ||||||||||  Fluzone High-Dose Quadrivalent (influenza vaccine) / Evotec, Sanofi
    Enrollment closed, Enrollment change, Trial primary completion date:  Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing In Gammopathy Patients (clinicaltrials.gov) -  Jul 15, 2015   
    P1,  N=51, Active, not recruiting, 
    Active, not recruiting --> Completed Not yet recruiting --> Active, not recruiting | N=100 --> 51 | Trial primary completion date: Aug 2015 --> Dec 2015